“Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): A feasibility study” by Mulliez et al. (March 2022, Volume 170)

Abstract

We read with particular interest the paper titled “Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): A feasibility study” [ [1] Mulliez T. Miedema G. Van Parijs H. Hottat N. Vassilieff M. Gillet E. et al. Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): A feasibility study. Radiother Oncol. 2022; 170 (PMID: 35257850): 118-121https://doi.org/10.1016/j.radonc.2022.02.033 Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar ]. Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): A feasibility studyRadiotherapy and OncologyVol. 170PreviewPre-operative 5-fraction breast radiotherapy followed by immediate breast-sparing surgery and sentinel node procedure was feasible in 14 patients with 15 clinical early-stage breast cancers. However wound problems occurred frequently and was documented in 5 of the 14 patients: 2 patients with a mastitis needing antibiotics, 2 patients developed a fistula with exudate needing antibiotics and local disinfection and 1 patient developed a fistula needing surgical reintervention. Other acute and late iatrogenic events were rather limited. Full-Text PDF Open AccessPre-OPerative Accelerated breast Radio Therapy (POPART): a largely unknown worldRadiotherapy and OncologyVol. 174PreviewWe thank the authors [1] for their interest and valuable comments regarding our article “Pre-OPerative Accelerated RadioTherapy for early stage breast cancer patients (POPART): a feasibility study”[2]. Full-Text PDF